Forteo is a medication that you typically inject yourself once daily. It comes in a prefilled pen designed for ease of use. It’s crucial to follow the instructions provided by your doctor or nurse very carefully.

• Daily Injection: Inject Forteo once every day. You can choose a consistent time that works best for you, but it should be around the same time each day.
• Subcutaneous Injection: The injection is given under the skin (subcutaneously) in your thigh or lower abdomen. Your healthcare provider will show you exactly how to do this.
• Rotate Injection Sites: To prevent skin irritation, choose a different injection site each day.
• Swallow Whole: Forteo comes in a liquid solution in the pen; it is not swallowed.
• Storage: The Forteo pen must be stored in the refrigerator at all times. Do not freeze it. Discard the pen 28 days after its first use, even if there is still some medicine left.
• First Doses: It’s a good idea to sit or lie down for a short period after your first few injections, as some people may experience dizziness or lightheadedness.

Forteo (teriparatide) works in a unique way to strengthen bones. It is a synthetic version of parathyroid hormone (PTH), a natural hormone that helps control calcium levels in the body and plays a role in bone health. When given intermittently (once daily) rather than continuously, Forteo has a special effect:

• Stimulates Osteoblasts: Forteo primarily acts on osteoblasts, which are the cells responsible for building new bone. By stimulating these cells, it encourages the formation of new bone tissue, leading to increased bone mineral density.
• Increases Bone Turnover: While it promotes bone formation, it also influences bone remodeling, ensuring a healthy balance of bone formation and resorption.
• Enhances Calcium Absorption: PTH also helps the body absorb more calcium from food and increases calcium reabsorption in the kidneys, making more calcium available for bone building.

This direct bone-building action sets Forteo apart from many other osteoporosis treatments that mainly work by slowing down bone loss.

Like all medications, Forteo can cause side effects, although not everyone will experience them. Most common side effects are usually mild and temporary.

• Common Side Effects:
  • Nausea
  • Joint pain (arthralgia), general body aches
  • Headache
  • Dizziness or lightheadedness (especially after the first few doses, due to a temporary drop in blood pressure upon standing)
  • Leg cramps
  • Injection site reactions (pain, redness, swelling, or bruising at the site of injection)
• Less Common/Serious Side Effects:
  • High Blood Calcium (Hypercalcemia): Forteo can cause a temporary increase in blood calcium levels after injection. This is usually mild but can lead to symptoms like nausea, vomiting, constipation, tiredness, or muscle weakness.
  • Osteosarcoma (Bone Cancer): In animal studies, Forteo caused an increase in bone tumors (osteosarcoma) at very high doses. While this has been very rare in human post-marketing data and the direct link is unclear, it is a serious warning. Due to this, the maximum lifetime exposure to Forteo is limited to 24 months.
  • Orthostatic Hypotension: A sudden drop in blood pressure when standing up, leading to dizziness or fainting, particularly with initial doses.
  • Allergic Reactions: Rare but serious allergic reactions can occur, with symptoms like rash, itching, swelling, severe dizziness, or trouble breathing.

Always report any new or worsening side effects to your healthcare provider.

Before and during treatment with Forteo, it’s crucial to be aware of important warnings and precautions to ensure safe use.

• Risk of Osteosarcoma: Forteo has a “black box warning” regarding the risk of osteosarcoma (a type of bone cancer) observed in animal studies. For this reason, Forteo is generally not recommended for individuals with an increased risk of osteosarcoma, such as those with Paget’s disease of the bone, unexplained high levels of alkaline phosphatase, open epiphyses (growing bones in children/young adults), or a history of radiation therapy to the skeleton or bone cancer.
• Limited Treatment Duration: The maximum lifetime use of Forteo is 24 months. This limit is in place due to the theoretical risk of osteosarcoma.
• High Blood Calcium (Hypercalcemia): Forteo can temporarily raise blood calcium levels. It should not be used in people with pre-existing high blood calcium levels.
• Kidney Stones: Use with caution in patients with active or recent kidney stones, as Forteo may worsen this condition.
• Kidney Impairment: Patients with severe kidney disease should avoid Forteo.
• Orthostatic Hypotension: Be aware of the possibility of dizziness or lightheadedness upon standing, especially during the first few doses. Take your first doses in a setting where you can sit or lie down immediately if needed.
• Pregnancy and Breastfeeding: Forteo is not recommended during pregnancy or breastfeeding. Women who can become pregnant should use effective birth control during treatment.

When using Forteo, it’s important to inform your doctor about all other medications, supplements, and herbal products you are taking, as interactions can occur.

• Digoxin: Forteo can temporarily increase blood calcium levels. If you are taking digoxin (a heart medication), high calcium levels can increase the risk of digoxin toxicity, which can lead to serious heart problems. Forteo should be used with caution in patients taking digoxin, and calcium levels may need to be monitored.
• Other Medications that Affect Calcium: Be cautious with other medications that can also raise blood calcium levels, such as certain diuretics (e.g., hydrochlorothiazide) or large doses of calcium and Vitamin D supplements, as this could lead to excessively high calcium levels.
• Calcipotriene/Calcitriol: These are forms of Vitamin D used for skin conditions, and their topical use can potentially increase calcium absorption, so caution is advised.
• No Known Food Interactions: Forteo does not have known interactions with food.

Always maintain an updated list of your medications to share with your healthcare provider to ensure safe treatment.

The dosage of Forteo is very specific and must be strictly followed as prescribed by your doctor.

• Standard Dose: The recommended dosage of Forteo is 20 micrograms (mcg) injected subcutaneously (under the skin) once daily.
• Fixed Dose: Forteo comes in a prefilled pen that delivers this fixed daily dose. It is not approved for use at higher dosages, and your doctor is unlikely to increase your dose.
• Administration: It should be injected once daily into the thigh or lower abdomen. Rotating the injection site daily is important to prevent skin irritation.
• Duration of Therapy: The maximum recommended duration of treatment with Forteo is 24 months in a patient’s lifetime. Your doctor will discuss what steps to take after this period, usually transitioning to another osteoporosis medication.
• Missed Dose: If you miss a dose and remember it on the same day, take it as soon as you remember. If you don’t remember until the next day, skip the missed dose and take your next regularly scheduled dose. Do not take two doses in one day to make up for a missed dose.
• Storage: Always store the Forteo pen in the refrigerator. Discard the pen 28 days after its first use, even if there’s medicine remaining.

Forteo is a prescription-only medication and requires careful medical supervision.

• Medical Consultation and Diagnosis: You must have a thorough medical evaluation by a licensed healthcare provider to determine if Forteo is appropriate for your condition. This involves diagnosing severe osteoporosis, assessing your risk for fractures, and evaluating any underlying medical conditions.
• High-Risk Criteria: Forteo is typically reserved for individuals at high risk for fracture, those with a history of osteoporotic fractures, or those who have failed or are intolerant to other available osteoporosis therapies. Specific bone density measurements (T-scores) and fracture risk assessments (e.g., FRAX score) may be part of the criteria.
• Exclusion Criteria: Your doctor will assess for conditions that contraindicate Forteo use, such as certain bone diseases, a history of radiation therapy to the skeleton, or unexplained high calcium levels.
• Patient Training: Since Forteo is self-administered via injection, your healthcare provider or a trained nurse will provide detailed instructions and training on how to properly use the injection pen.
• Monitoring: Regular follow-up appointments and monitoring of calcium levels are necessary during treatment. The limited duration of therapy (24 months lifetime) also requires careful tracking by your healthcare provider.

What is Forteo used for? Treatment of osteoporosis in postmenopausal women and men at high risk for fractures

2. What is the active ingredient in Forteo? Teriparatide (recombinant human parathyroid hormone 1–34)

3. What drug class does Forteo belong to? Parathyroid hormone analog

4. Is Forteo a controlled substance? No

5. Is Forteo available in generic form? Yes

6. How is Forteo administered? Subcutaneous injection once daily

7. What strengths are available? 250 mcg/mL in a 2.4 mL prefilled pen (600 mcg total)

8. What is the usual dosage? 20 mcg once daily

9. What are common side effects? Leg cramps, dizziness, nausea, headache, and injection site reactions

10. Can Forteo cause serious reactions? Yes—hypercalcemia, orthostatic hypotension, and increased risk of osteosarcoma (boxed warning)

11. Is Forteo safe during pregnancy? Not recommended

12. Is a prescription required? Yes

13. Is Forteo available in Pakistan? Limited availability; may be imported through specialty pharmacies

14. How long can Forteo be used? Maximum of 2 years in a lifetime

15. Is Forteo used in men? Yes—for osteoporosis due to hypogonadism or other causes

16. What monitoring is needed during use? Serum calcium, renal function, and bone mineral density

17. Can Forteo be used with other osteoporosis drugs? Not concurrently; may be followed by bisphosphonates

18. What are contraindications? Paget’s disease, unexplained elevated alkaline phosphatase, prior radiation therapy to bones

19. What is the mechanism of action? Stimulates osteoblast activity → increases bone formation

20. What are similar drugs? Abaloparatide (Tymlos), bisphosphonates (alendronate, zoledronic acid)